Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 43Carcinoma, Hepatocellular 41Carcinoma, Non-Small-Cell Lung 17Colorectal Neoplasms 14Breast Neoplasms 14Small Cell Lung Carcinoma 12Sarcoma 11Ovarian Neoplasms 11Nasopharyngeal Carcinoma 11Triple Negative Breast Neoplasms 10Lung Neoplasms 10Cholangiocarcinoma 10Esophageal Squamous Cell Carcinoma 9Esophageal Neoplasms 9Osteosarcoma 8Biliary Tract Neoplasms 8Advanced Gastric Cancer 8Neoplasms 6Head and Neck Neoplasms 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Recurrence 5Pancreatic Neoplasms 5Neoplasm Metastasis 5Liver Neoplasms 5Glioma 5Drug-Related Side Effects and Adverse Reactions 4Thyroid Neoplasms 3Melanoma 3Gastrointestinal Neoplasms 3

Interventions

nintedanib 2durvalumab 2Radiotherapy 2Immunotherapy 2tislelizumab 1sugemalimab 1sintilimab 1pembrolizumab 1camrelizumab 1beclomethasone 17-monopropionate 1aumolertinib 1atezolizumab 1apatinib 1Tomography, Emission-Computed, Single-Photon 1Surveys and Questionnaires 1Respiratory Function Tests 1Prednisone 1Nivolumab 1Nicorandil 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1Hyperbaric Oxygenation 1Esophagectomy 1Disulfides 1Dexamethasone 1Cisplatin 1Breath Holding 1Angiogenesis Inhibitors 1Adrenal Cortex Hormones 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Radiation Pneumonitis × apatinib × Clear all
NCT06700421 2024-11-22

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

Chongqing University Cancer Hospital

Phase 2 Active not recruiting
32 enrolled

Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡